U.S. Cervical Cancer Screening, Diagnostics, And Pre-cancerous Dysplasia Lesion Treatment Market Size & Outlook
Related Markets
U.S. cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market highlights
- The U.S. cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market generated a revenue of USD 2,881.6 million in 2024 and is expected to reach USD 5,413.3 million by 2035.
- The U.S. market is expected to grow at a CAGR of 6% from 2025 to 2035.
- In terms of segment, cervical cancer screening was the largest revenue generating type in 2024.
- Cervical Cancer Screening is the most lucrative type segment registering the fastest growth during the forecast period.
Cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market data book summary
| Market revenue in 2024 | USD 2,881.6 million |
| Market revenue in 2035 | USD 5,413.3 million |
| Growth rate | 6% (CAGR from 2025 to 2035) |
| Largest segment | Cervical cancer screening |
| Fastest growing segment | Cervical Cancer Screening |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2035 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cervical Cancer Screening, Cervical Cancer Diagnostics, Pre-cancerous Lesion Treatment |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.2% of the global cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2035.
- In North America, U.S. cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market is projected to lead the regional market in terms of revenue in 2035.
- Canada is the fastest growing regional market in North America and is projected to reach USD 741.3 million by 2035.
Cervical cancer screening was the largest segment with a revenue share of 51.3% in 2024. Horizon Databook has segmented the U.S. cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market based on cervical cancer screening, cervical cancer diagnostics, pre-cancerous lesion treatment covering the revenue growth of each sub-segment from 2018 to 2035.
U.S. cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment Market is growing significantly. Projections for 2025 indicate that the American Cancer Society estimates 13,360 new invasive cervical cancer cases and 4,320 deaths in the United States.
Cervical cancer primarily affects women aged 35-44, with the average age at diagnosis being around 50. Notably, over 20% of cases are diagnosed in women over 65, particularly among those who were unscreened earlier in life. In the realm of treatment innovations, several key clinical trials are shaping the future of cervical cancer management.
The INTERLACE Trial (2023) evaluated induction chemotherapy followed by chemoradiotherapy (CRT) versus CRT alone in patients with locally advanced cervical cancer, demonstrating improved progression-free survival (HR: 0.65; p=0.013) and overall survival (HR: 0.61; p=0.04).
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Scope
Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| MedGyn Products | View profile | 51-100 | Addison, Illinois, United States, North America | https://www.medgyn.com |
| Utah Medical Products Inc | View profile | 190 | 7043 South 300 West, Midvale, UT, United States, 84047 | http://www.utahmed.com |
| CooperSurgical | View profile | 501-1000 | Trumbull, Connecticut, United States, North America | http://www.coopersurgical.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
US Type - Cervical Cancer Screening, Diagnostics, And Pre-cancerous Dysplasia Lesion Treatment Market size, 2024 - 2035 (US$M)
U.S. Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Outlook Share, 2024 & 2035 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
